Literature DB >> 12699019

Changes in caffeine states enhance return of fear in spider phobia.

Jayson L Mystkowski1, Susan Mineka, Laura L Vernon, Richard E Zinbarg.   

Abstract

Treatment of phobias is sometimes followed by a return of fear. Animal and human research has shown that changes in external and internal contexts between the time of treatment and follow-up tests often enhance return of fear. The present study examined whether shifts in caffeine (C) state would enhance return of fear. Participants who were highly afraid of spiders (n = 43) were treated in 1-session exposure-based therapy and tested for follow-up 1 week later. Participants were randomly assigned to 1 of 4 groups and received either placebo (P) or C at treatment and follow-up sessions: CC, PP, CP, and PC. Results demonstrated state-dependent learning. Participants experiencing incongruent drug states during treatment and follow-up (CP and PC) exhibited greater return of fear than those experiencing congruent drug states (CC and PP).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12699019     DOI: 10.1037/0022-006x.71.2.243

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  8 in total

1.  Cholinergic Modulation of Exposure Disrupts Hippocampal Processes and Augments Extinction: Proof-of-Concept Study With Social Anxiety Disorder.

Authors:  Michelle G Craske; Michael Fanselow; Michael Treanor; Alexander Bystritksy
Journal:  Biol Psychiatry       Date:  2019-04-19       Impact factor: 13.382

2.  Maximizing exposure therapy: an inhibitory learning approach.

Authors:  Michelle G Craske; Michael Treanor; Christopher C Conway; Tomislav Zbozinek; Bram Vervliet
Journal:  Behav Res Ther       Date:  2014-05-09

3.  Benzodiazepines: Revisiting Clinical Issues in Treating Anxiety Disorders.

Authors: 
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2005

Review 4.  Cognitive enhancers for anxiety disorders.

Authors:  Stefan G Hofmann; Jasper A J Smits; Anu Asnaani; Cassidy A Gutner; Michael W Otto
Journal:  Pharmacol Biochem Behav       Date:  2010-12-04       Impact factor: 3.533

5.  A high-throughput clinical assay for testing drug facilitation of exposure therapy.

Authors:  Thomas L Rodebaugh; Cheri A Levinson; Eric J Lenze
Journal:  Depress Anxiety       Date:  2013-01-02       Impact factor: 6.505

6.  Cholinergic blockade frees fear extinction from its contextual dependency.

Authors:  Moriel Zelikowsky; Timothy A Hast; Rebecca Z Bennett; Michael Merjanian; Nathaniel A Nocera; Ravikumar Ponnusamy; Michael S Fanselow
Journal:  Biol Psychiatry       Date:  2012-09-12       Impact factor: 13.382

7.  Attending to emotional cues for drug abuse: bridging the gap between clinic and home behaviors.

Authors:  Michael W Otto; Conall M O' Cleirigh; Mark H Pollack
Journal:  Sci Pract Perspect       Date:  2007-04

8.  Neuroenhancement of Exposure Therapy in Anxiety Disorders.

Authors:  Stefan G Hofmann; Elizabeth A Mundy; Joshua Curtiss
Journal:  AIMS Neurosci       Date:  2015
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.